AlphaCentric Advisors »

Inotiv shares owned by AlphaCentric Advisors

Quarter-by-quarter ownership of Inotiv (NOTV) shares owned by AlphaCentric Advisors from 13F filings

Historical chart of AlphaCentric Advisors investment in Inotiv

Tip: Access up to 7 years of quarterly data

All positions including Inotiv held by AlphaCentric Advisors consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Inotiv by AlphaCentric Advisors

Quarter filed Position value Share count Share price at filing
2024-12-31 $163k 39k 4.14

More positions owned by AlphaCentric Advisors

Eli Lilly & Co. (LLY)
UnitedHealth (UNH)
Johnson & Johnson (JNJ)
Ishares Tr 1 3 Yr Treas Bd (SHY)
Abbvie (ABBV)
Merck & Co (MRK)
Thermo Fisher Scientific (TMO)
Astrazeneca Sponsored Adr (AZN)
Novo-nordisk A S Adr (NVO)
Globus Med Cl A (GMED)
Invesco Exchange Traded Fd T S&p500 Pur Val (RPV)
Ishares Tr Rus 1000 Val Etf (IWD)
Intuitive Surgical Com New (ISRG)
Lamar Advertising Cl A (LAMR)
Boston Scientific Corporation (BSX)

View all positions for AlphaCentric Advisors

Top funds holding Inotiv

Vanguard Group
Balyasny Asset Management
Renaissance Technologies
Vantage Point Financial
Geode Capital Management
UBS Group
BlackRock
Citadel Advisors
GSA Capital Partners
Morgan Stanley
Jane Street
KPP Advisory Services
Acorn Creek Capital
EHP Funds
Mount Lucas Management Corporation

View all funds holding Inotiv